Topical EGF Inhibitor was being tested in this patent, George Cotsarelis,

http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=8252749.PN.&OS=PN/8252749&RS=PN/8252749

» http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=8252749.PN.&OS=PN/8252749&RS=PN/8252749

Where do you see that it was tested on a patient? The only example I see is a human skin xenograft on mice.

» »
» http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=8252749.PN.&OS=PN/8252749&RS=PN/8252749
»
»
» Where do you see that it was tested on a patient? The only example I see is
» a human skin xenograft on mice.

Topical EGF Inhibitor was being tested in this patent, not patient =)

Whatever happened to the member BACCY? From what I remember, he had some success with an EGF inhbitor and wounding.

Ahhh…damn. Wishful thinking. This is an old patent I believe, I don’t think Baccy grew any new hair. Follica has not tested this on humans to my knowledge, and I have no idea what they are up to.

The EGFR pathway is really complicated I’m afraid.

In case you want some reading:
http://anagen.ucdavis.edu/1503/reviews/egfr/alexandrescu.html